Avenanthramide C as a novel candidate to alleviate osteoarthritic pathogenesis
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Osteoarthritis (OA) is a degenerative disorder that can result in the loss of articular cartilage. No effective treatment against OA is currently available. Thus, interest in natural health products to relieve OA symptoms is increasing. However, their qualities such as efficacy, toxicity, and mechanism are poorly understood. In this study, we determined the efficacy of avenanthramide (Avn)-C extracted from oats as a promising candidate to prevent OA progression and its mechanism of action to prevent the expression of matrix-metalloproteinases (MMPs) in OA pathogenesis. Interleukin-1 beta (IL-1β), a proinflammatory cytokine as a main causing factor of cartilage destruction, was used to induce OAlike condition of chondrocytes in vitro. Avn-C restrained IL-1β- mediated expression and activity of MMPs, such as MMP-3, -12, and -13 in mouse articular chondrocytes. Moreover, Avn-C alleviated cartilage destruction in experimental OA mouse model induced by destabilization of the medial meniscus (DMM) surgery. However, Avn-C did not affect the expression of inflammatory mediators (Ptgs2 and Nos) or anabolic factors (Col2a1, Aggrecan, and Sox9), although expression levels of these genes were upregulated or downregulated by IL-1β, respectively. The inhibition of MMP expression by Avn-C in articular chondrocytes was mediated by p38 kinase and c-Jun N-terminal kinase (JNK) signaling, but not by ERK or NF-κB. Interestingly, Avn-C added with SB203580 and SP600125 as specific inhibitors of p38 kinase and JNK, respectively, enhanced its inhibitory effect on the expression of MMPs in IL-1β treated chondrocytes. Taken together, these results suggest that Avn-C is an effective candidate to prevent OA progression and a natural health product to relieve OA pathogenesis.
Abstract
Osteoarthritis (OA) is a degenerative disorder that can result in the loss of articular cartilage. No effective treatment against OA is currently available. Thus, interest in natural health products to relieve OA symptoms is increasing. However, their qualities such as efficacy, toxicity, and mechanism are poorly understood. In this study, we determined the efficacy of avenanthramide (Avn)-C extracted from oats as a promising candidate to prevent OA progression and its mechanism of action to prevent the expression of matrix-metalloproteinases (MMPs) in OA pathogenesis. Interleukin-1 beta (IL-1β), a proinflammatory cytokine as a main causing factor of cartilage destruction, was used to induce OAlike condition of chondrocytes in vitro. Avn-C restrained IL-1β- mediated expression and activity of MMPs, such as MMP-3, -12, and -13 in mouse articular chondrocytes. Moreover, Avn-C alleviated cartilage destruction in experimental OA mouse model induced by destabilization of the medial meniscus (DMM) surgery. However, Avn-C did not affect the expression of inflammatory mediators (Ptgs2 and Nos) or anabolic factors (Col2a1, Aggrecan, and Sox9), although expression levels of these genes were upregulated or downregulated by IL-1β, respectively. The inhibition of MMP expression by Avn-C in articular chondrocytes was mediated by p38 kinase and c-Jun N-terminal kinase (JNK) signaling, but not by ERK or NF-κB. Interestingly, Avn-C added with SB203580 and SP600125 as specific inhibitors of p38 kinase and JNK, respectively, enhanced its inhibitory effect on the expression of MMPs in IL-1β treated chondrocytes. Taken together, these results suggest that Avn-C is an effective candidate to prevent OA progression and a natural health product to relieve OA pathogenesis.
참고문헌 (27)
- Loeser RF, "Osteoarthritis : a disease of the joint as an organ", Arthritis Rheum, 64, pp.1697~1707 (2012)
- Yang S, "Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction", Nat Med, 16, pp.687~693 (2010)
- Goldring MB, "Osteoarthritis", J Cell Physiol, 213, pp.626~634 (2007)
- Hashimoto M, "Molecular network of cartilage homeostasis and osteoarthritis", Med Res Rev, 28, pp.464~481 (2008)
- Roman-Blas JA, "NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis", Osteoarthr Cartil, 14, pp.839~848 (2006)
- Kim JH, "Regulation of the catabolic cascade in osteoarthritis by the zinc-ZIP8-MTF1axis", Cell, 156, pp.730~743 (2014)
- Mengshol JA, "Interleukin-1 induction of collagenase 3(matrix metalloproteinase 13)gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB : differential regulation of collagenase 1 and collagenase 3", Arthritis Rheum, 43, pp.801~811 (2000)
- Zeng Li, "Icariin inhibits MMP 1, MMP 3 and MMP 13 expression through MAPK pathways in IL 1β stimulated SW1353chondrosarcoma cells", Mol Med Rep, 15, pp.2853~2858 (2017)
- Chang SH, "Excessive mechanical loading promotes osteoarthritis through the gremlin-1-NF-κB pathway", Nat Commun, 10, pp.1442~ (2019)
- Roman-Blas JA, "NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis", Osteoarthr Cartil, 14, pp.839~848 (2006)
- Collins FW, "Oat phenolics : avenanthramides, novel substituted N-cinnamoylanthranilate alkaloids from oat groats and hulls", J Agric Food Chem, 37, pp.60~66 (1989)
- Othman RA, "Cholesterol-lowering effects of oat β-glucan", Nutr Rev, 69, pp.299~309 (2011)
- Peterson, "Oat avenanthramides exhibit antioxidant activities in vitro", Food Chem, 79, pp.473~478 (2002)
- Emmons CL, "Antioxidant capacity of oat(Avena sativa L.) extracts. 2. In vitro antioxidant activity and contents of phenolic and tocol antioxidants", J Agric Food Chem, 47, pp.4894~4898 (1999)
- Guo W, "Avenanthramides inhibit proliferation of human colon cancer cell lines in vitro", Nutr Cancer, 62, pp.1007~1016 (2010)
- Guo W, "Avenanthramides, polyphenols from oats, inhibit IL-1betainduced NF-kappaB activation in endothelial cells", Free Radic Biol Med, 44, pp.415~429 (2008)
- Kang C, "Anti-inflammatory effect of avenanthramides via NF-κB pathways in C2C12 skeletal muscle cells", Free Radic Biol Med, 117, pp.30~36 (2018)
- 임원청, "Avenanthramide C suppresses hypoxia-induced cyclooxygenase-2 expression through sirtuin1 activation in non-small-cell lung cancer cells", Animal Cells and Systems, 24(2), pp.79~83 (2020), 한국통합생물학회
- Nakasa T, "Correlation between subchondral bone plate thickness and cartilage degeneration in osteoarthritis of the ankle", Foot Ankle Int, 35, pp.1341~1349 (2014)
- Saklatvala J, "Inflammatory signaling in cartilage : MAPK and NF-kappaB pathways in chondrocytes and the use of inhibitors for research into pathogenesis and therapy of osteoarthritis", Curr Drug Targets, 8, pp.305~313 (2007)
- Liu T, "NF-κB signaling in inflammation", Signal Transduct Target Ther, 2, pp.17023~ (2017)
- Guilak F, "Biomechanical factors in osteoarthritis", Best Pract Res Clin Rheumatol, 25, pp.815~823 (2011)
- Kapoor M, "Role of proinflammatory cytokines in the pathophysiology of osteoarthritis", Nat Rev Rheumatol, 7, pp.33~42 (2011)
- Yun S, "Transcription factor Sp1 phosphorylation induced by shear stress inhibits membrane type 1-matrix metalloproteinase expression in endothelium", J Biol Chem, 277, pp.34808~34814 (2002)
- Pan MR, "Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK", Sp1-mediated transcription, 2002, pp.277, 32775~32780
- Pulai JI, "NF-kappa B mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments", J Immunol, 174, pp.5781~5788 (2005)
- Loeser RF, "Mitogen-activated protein kinases as therapeutic targets in osteoarthritis", Curr Opin Rheumatol, 20, pp.581~586 (2008)